Log in to save to my catalogue

Controlled Attenuation Parameter (CAP) with the XL Probe of the Fibroscan®: A Comparative Study with...

Controlled Attenuation Parameter (CAP) with the XL Probe of the Fibroscan®: A Comparative Study with...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1905734464

Controlled Attenuation Parameter (CAP) with the XL Probe of the Fibroscan®: A Comparative Study with the M Probe and Liver Biopsy

About this item

Full title

Controlled Attenuation Parameter (CAP) with the XL Probe of the Fibroscan®: A Comparative Study with the M Probe and Liver Biopsy

Publisher

New York: Springer US

Journal title

Digestive diseases and sciences, 2017-09, Vol.62 (9), p.2569-2577

Language

English

Formats

Publication information

Publisher

New York: Springer US

More information

Scope and Contents

Contents

Introduction
Controlled attenuation parameter (CAP) is a new method for the diagnosis of steatosis. Until now, CAP was available only with the M probe of the Fibroscan. The aim of this study was to evaluate the diagnostic performance of CAP with the XL probe versus CAP with the M probe, using liver biopsy (LB) as gold standard.
Patients and M...

Alternative Titles

Full title

Controlled Attenuation Parameter (CAP) with the XL Probe of the Fibroscan®: A Comparative Study with the M Probe and Liver Biopsy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1905734464

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1905734464

Other Identifiers

ISSN

0163-2116

E-ISSN

1573-2568

DOI

10.1007/s10620-017-4638-3

How to access this item